COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report- September 2020 Update
COVID-19 Pipeline Analysis
The September 2020 updated COVID-19 report identifies 440 companies investing in therapy and vaccination products. Around 24 companies have advanced their products into Phase 3 and around 15 companies are in Phase 2/3. Pipeline candidates of 114 companies are in phase 1 or phase 2. 23 companies are in IND/CTA filed phase.
The early development COVID-19 product pipeline is much stronger with 135 companies investing their R&D resources in preclinical COVID, 127 companies developing Research phase products.
The research report is a comprehensive market research on COVID-19 pipeline products detailing the companies, drug and vaccine candidates, their current status, historical developments and other progress.
The COVID pandemic is resulting in significant health and economic impact on individuals and businesses across the world. Accordingly, companies like Inovio, Pfizer, Johnson and Johnson, Novavax are forming joint ventures, GlaxoSmithKline is extending access to vaccine adjuvant platform, and Sanofi is sharing its expertise with BARDA among others.
Following the release of SARS-CoV-2 genome sequence, majority of companies ranging from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) are focusing on vaccine candidates for COVID-19.
COVID-19 Clinical Trials Analysis
The section presents a comprehensive 1800 page analysis on all clinical trials across 96 countries worldwide. The report provides phase wise analysis, region wise clinical trials, trials sponsored directly by companies and through universities, drugs under development, trials in emerging economies and developed countries, and subjects enrolled across phases, geographies, companies, trial status, trial types and countries.
During the 2019 to August 2020 observation period, 1194 COVID-19 trials have been initated and an additional 503 clinical trials are planned to commence. Of the total 1697 trials studied in the research, 726 trials are in Phase 2, 549 trials are in Phase 3, 220 trials in Phase 0 and Phase 1, and 183 trials in Phase 4. In terms of enrollment, 62% of subjects are recruited/planned for Phase 3.
Around 84% of trials are recruiting or planning to recruit subjects for their pipeline product development. Over 21% of trials are directly sponsored by pharmaceutical companies with the remaining 79% being sponsored indirectly by companies or sponsored by institutions.
Among countries, the US stood the largest market worldwide, accounting for 441 clinical trials. Among economy types, advanced and emerging economies share an almost equal volume of trials with the former accounting for 53% of trial count.
Overall, during the period under consideration, new clinical trial count has been steadily increasing. Further, with robust market outlook, the number of clinical trials and enrolment is also expected to increase steadily through 2022.
Potential Drugs under analysis in COVID-19 clinical trials
Abatacept, Abidole , Abivertinib, ABX464, Acalabrutinib, ACE inhibitor, Acetaminophen, acetylsalicylic acid, adalimumab, Aescinate , AG0301, Alafenamide , Alendronic Acid , Alkaline phosphatase, Almitrine, alpha-Interferon, Alteplase, Ambrisentan, Amiodarone, Amlodipine besilate, Ampion, AMY-101, ANAKINRA, ANG-3777, Angiotensin 1-7, Angiotensin receptor blocker, Anluohuaxian, AOIM - Z , Apilimod Dimesylate , Apixaban, APL-9, apocynin, Apremilast, Aprepitant, APROTININ, Arbidol Hydrochloride, ARCT-021, Argatroban, ARGX-117, ArtemiC, Artemisinin, ascorbic acid, Aspirin, Astegolimab, ASUNERCEPT, AT-001, AT-527, Atazanavir , ATI-450, Atorvastatin, Atovaquone, ATYR1923, avdoralimab, Avigan, Aviptadil, AVM0703, AZD1656, AZD7442, AZD7986, Azithromycin, Azivudine, azoximer bromide, Babaodan, Bactek-R, Baidu Duan Fang, Baloxavir Marboxil, Bardoxolone methyl, BARICITINIB, BAT2020, BBV152, BDB-001 , bemcentinib, Bemiparin, Berberine, betafron, Bevacizumab, Bicalutamide, BIO 300, BIO101, Biomodulina T, bismuth potassium citrate, Bivalirudin , BLD-2660, BMS-986253, BNT162, Botulinum Neurotoxin, Bovine Lipid Extract Surfactant, Brensocatib, Brequinar, BRII-196, BRII-198, bromelain, Bromhexine, Bucillamine, Budesonide, Calcifediol, Camostate mesylate, Camrelizumab, Canakinumab , Candesartan, Carrimycin, Ceftriaxone, Celebrex , Cenicriviroc, CERC-002, chloroquine , Chloroquine Diphosphate, Chloroquine phosphate, Chlorpromazine, Cholecalciferol, Ciclesonide, CICLOSPORIN, CIGB 2020 vaccine, CIGB 300 , CIGB-258 Peptide , CK0802, Clarithromycin, clavulanate, Clazakizumab, CLEVIRA , Clevudine, Clindamycin, Clofazimine, Clopidogrel, Cobicistat, Colchicine, corticosteroid , Cospherunate, CPI-006, Crizanlizumab, Crocetin, CSA0001, cyclosporin, CYNK-001, CYP-001, CYT107, Daclatasvir, Dalteparin, Danoprevir, Dapagliflozin, DARUNAVIR, DAS181, Decitabine, Deferiprone, Deferoxamine, Defibrotide, Degarelix, Dendrobium candidum, Desferal, Desidustat, Dexamethasone, dextrose, DFV890, diltiazem, Diphenhydramine, Dipyridamole, Disulfiram, Dociparastat sodium, Dolquine, Dornase Alfa, Doxycycline, DUR-928, Dutasteride, Duvelisib, ebastine, Ebselen, EC-18, Eculizumab, edaravone, EDP1815, EIDD-2801, Emapalumab, Emtricitabine, Enoxaparin, Enzalutamide, EPARINA, Estradiol, Etoposide, F-652, Famotidine, Favipiravir, Febuxostat, Fingolimod, Fisetin, Fluoxetine, Fluvoxamine, Folic Acid, Fondapariniux, Formoterol, fostamatinib disodium hexahydrate, FT516, Galidesivir, Garadacimab, Gemtuzumab ozogamicin, Gimsilumab, GLS-1200, GS-5734, GX-19, HA330, Heberon Alfa R , Heparin, Hesperidin, hydrocortisone, Hyperbaric Oxygen, Ibrutinib, Ibudilast, Ibuprofen, Icatibant, Icosapent ethyl, IFX-1, Iloprost , ILT101, Imatinib, IMM-101, IMU-838, Indomethacin, Infliximab, INM005, INO-4800, Interferon Alfa, interferon beta, Isoflurane, Isoprinosine, Isotretinoin , itolizumab, ITRACONAZOLE, Ivermectin, Ixekizumab , Jakotinib hydrochloride, JS016, KB109 , KBP-201 , Ketamine, Khorasan asafoetida, kolimycin, Lactoferrin, lanadelumab, Lariam, L-ascorbic acid, LAU-7b, LB1148, L-cysteine, Ledipasvir, Leflunomide, Lenalidomide, Lenzilumab, Leronlimab, Levamisole, Levilimab, Lianhua Qingwen , Linagliptin, Lipoic acid, Losartan , Losmapimod , Lucinactant, LY3127804, LY3819253, M5049, Maraviroc, MAS825, Masitinib mesilate, mavrilimumab, MEDI3506, MEFLOQUINE, Melatonin, Melphalan, Meplazumab , Merimepodib, metenkefalin, Metformin, Methotrexate, methylprednisolone , metoprolol tartrate, metronidazole, midazolam, minocycline, MK-5475, Moxibustion , mRNA-1273, MRx-4DP0004, Mucodentol, MultiStem, MVC-COV1901, Mycobacterium w, N acetylcysteine, N-803, NA-831, N-Acetyl cysteine, NADROPARIN, Nafamostat Mesylate, Naltrexone, Namilumab, nangibotide, nanocurcumin, Naproxen, NasoVAX, Nebulised heparin, Nelfinavir, Niacin-Tannin, Niclosamide, Nifedipine, Nintedanib , Nitazoxanide , Nivolumab , Noscapine, Novaferon, NP-120 , NT-I7, OctaplasLG, olchicine/Statins, Olokizumab, Omegaven, Omeprazole, OP-101, Opaganib, Oseltamivir, Otilimab, Ozanimod, Pamrevlumab, PB1046, Pegylated interferon lambda, Pembrolizumab, Pentaglobin, Pentoxifylline, Pertuzumab, PH94B, PHR160, Piclidenoson, Pioglitazone, Pirfenidone, Plitidepsin, PLX-PAD, Povidone-iodine, Prasugrel Hydrochloride, Prazosin, Prednisolone, Previfenon, Probiorinse, Progesterone, Prolongin, Propranolol Hydrochloride, Proxalutamide, PSC-04, PTC299, PUL-042, Pulmozyme, Pyramax, Pyridostigmine, qingfei detoxification, raltagravir, Ramelteon, Ramipril, Rapamycin, Ravulizumab, Razuprotafib, RBT-9, rednisolone, Reginmune , REGN10933, REGN10987, Remdesivir, Remestemcel-L, RESP301, resveratrol, Ribavirin, RITONAVIR, Ritonavir , Rivaroxaban, RPH-104, RTB101, Ruxolitinib, SAB-185, SAR443122, SARILUMAB, SBI-101, SCB-2019, SCTA01, Secukinumab, Secuquinumab, selenium, Selinexor, Septimeb, Sevoflurane, Shenfu, Sildenafil, Silibinin, Siltuximab, Silymarin, simvastatin, Sirolimus, Sirukumab, Sitagliptin, SivoMixx , Sofosbuvir, Spironolactone, STI-1499, sulfamethoxazole, sulfate, Sulodexide, TAK-671, Tamiflu, Tamoxifen, Tanacetum parthenium, Tannin, Tanreqing, TD-0903, TD139, Teicoplanin IV, Telmisartan, Tenecteplase, Tenofovir, Teprenone, Tetrandrine, thalidomide, Thymalfasin, Thymoquinone, Thymosin Alpha 1 , Tinzaparin , Tirofiban, TJ003234, TL-895, TMV-083, Tociliuzumab, Tradipitant, Tramadol, Tranexamic acid, Tranilast, Trastuzumab, Triazavirin, Tricholoma, tridecactide, Trifluoperazine, TRV027, TXA127, TY027, Ulinastatin, Umnifenovir, V591, vadadustat, VAFIDEMSTAT, Valsartan (Diovan), Vancomycin, Vazegepant , Velpatasvir, Veru-111, Videsil, Vidofludimus calcium, Virazole, VPM1002, XAV-19, XC221, Xinguan-1 , Xinguan-2 , Xiyanping , XPro1595, Xuebijing , yohimbine, Zanubrutinib, Zilucoplan, ZingiVir H, ?-Globulin
The September 2020 updated COVID-19 report identifies 440 companies investing in therapy and vaccination products. Around 24 companies have advanced their products into Phase 3 and around 15 companies are in Phase 2/3. Pipeline candidates of 114 companies are in phase 1 or phase 2. 23 companies are in IND/CTA filed phase.
The early development COVID-19 product pipeline is much stronger with 135 companies investing their R&D resources in preclinical COVID, 127 companies developing Research phase products.
The research report is a comprehensive market research on COVID-19 pipeline products detailing the companies, drug and vaccine candidates, their current status, historical developments and other progress.
The COVID pandemic is resulting in significant health and economic impact on individuals and businesses across the world. Accordingly, companies like Inovio, Pfizer, Johnson and Johnson, Novavax are forming joint ventures, GlaxoSmithKline is extending access to vaccine adjuvant platform, and Sanofi is sharing its expertise with BARDA among others.
Following the release of SARS-CoV-2 genome sequence, majority of companies ranging from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) are focusing on vaccine candidates for COVID-19.
COVID-19 Clinical Trials Analysis
The section presents a comprehensive 1800 page analysis on all clinical trials across 96 countries worldwide. The report provides phase wise analysis, region wise clinical trials, trials sponsored directly by companies and through universities, drugs under development, trials in emerging economies and developed countries, and subjects enrolled across phases, geographies, companies, trial status, trial types and countries.
During the 2019 to August 2020 observation period, 1194 COVID-19 trials have been initated and an additional 503 clinical trials are planned to commence. Of the total 1697 trials studied in the research, 726 trials are in Phase 2, 549 trials are in Phase 3, 220 trials in Phase 0 and Phase 1, and 183 trials in Phase 4. In terms of enrollment, 62% of subjects are recruited/planned for Phase 3.
Around 84% of trials are recruiting or planning to recruit subjects for their pipeline product development. Over 21% of trials are directly sponsored by pharmaceutical companies with the remaining 79% being sponsored indirectly by companies or sponsored by institutions.
Among countries, the US stood the largest market worldwide, accounting for 441 clinical trials. Among economy types, advanced and emerging economies share an almost equal volume of trials with the former accounting for 53% of trial count.
Overall, during the period under consideration, new clinical trial count has been steadily increasing. Further, with robust market outlook, the number of clinical trials and enrolment is also expected to increase steadily through 2022.
Potential Drugs under analysis in COVID-19 clinical trials
Abatacept, Abidole , Abivertinib, ABX464, Acalabrutinib, ACE inhibitor, Acetaminophen, acetylsalicylic acid, adalimumab, Aescinate , AG0301, Alafenamide , Alendronic Acid , Alkaline phosphatase, Almitrine, alpha-Interferon, Alteplase, Ambrisentan, Amiodarone, Amlodipine besilate, Ampion, AMY-101, ANAKINRA, ANG-3777, Angiotensin 1-7, Angiotensin receptor blocker, Anluohuaxian, AOIM - Z , Apilimod Dimesylate , Apixaban, APL-9, apocynin, Apremilast, Aprepitant, APROTININ, Arbidol Hydrochloride, ARCT-021, Argatroban, ARGX-117, ArtemiC, Artemisinin, ascorbic acid, Aspirin, Astegolimab, ASUNERCEPT, AT-001, AT-527, Atazanavir , ATI-450, Atorvastatin, Atovaquone, ATYR1923, avdoralimab, Avigan, Aviptadil, AVM0703, AZD1656, AZD7442, AZD7986, Azithromycin, Azivudine, azoximer bromide, Babaodan, Bactek-R, Baidu Duan Fang, Baloxavir Marboxil, Bardoxolone methyl, BARICITINIB, BAT2020, BBV152, BDB-001 , bemcentinib, Bemiparin, Berberine, betafron, Bevacizumab, Bicalutamide, BIO 300, BIO101, Biomodulina T, bismuth potassium citrate, Bivalirudin , BLD-2660, BMS-986253, BNT162, Botulinum Neurotoxin, Bovine Lipid Extract Surfactant, Brensocatib, Brequinar, BRII-196, BRII-198, bromelain, Bromhexine, Bucillamine, Budesonide, Calcifediol, Camostate mesylate, Camrelizumab, Canakinumab , Candesartan, Carrimycin, Ceftriaxone, Celebrex , Cenicriviroc, CERC-002, chloroquine , Chloroquine Diphosphate, Chloroquine phosphate, Chlorpromazine, Cholecalciferol, Ciclesonide, CICLOSPORIN, CIGB 2020 vaccine, CIGB 300 , CIGB-258 Peptide , CK0802, Clarithromycin, clavulanate, Clazakizumab, CLEVIRA , Clevudine, Clindamycin, Clofazimine, Clopidogrel, Cobicistat, Colchicine, corticosteroid , Cospherunate, CPI-006, Crizanlizumab, Crocetin, CSA0001, cyclosporin, CYNK-001, CYP-001, CYT107, Daclatasvir, Dalteparin, Danoprevir, Dapagliflozin, DARUNAVIR, DAS181, Decitabine, Deferiprone, Deferoxamine, Defibrotide, Degarelix, Dendrobium candidum, Desferal, Desidustat, Dexamethasone, dextrose, DFV890, diltiazem, Diphenhydramine, Dipyridamole, Disulfiram, Dociparastat sodium, Dolquine, Dornase Alfa, Doxycycline, DUR-928, Dutasteride, Duvelisib, ebastine, Ebselen, EC-18, Eculizumab, edaravone, EDP1815, EIDD-2801, Emapalumab, Emtricitabine, Enoxaparin, Enzalutamide, EPARINA, Estradiol, Etoposide, F-652, Famotidine, Favipiravir, Febuxostat, Fingolimod, Fisetin, Fluoxetine, Fluvoxamine, Folic Acid, Fondapariniux, Formoterol, fostamatinib disodium hexahydrate, FT516, Galidesivir, Garadacimab, Gemtuzumab ozogamicin, Gimsilumab, GLS-1200, GS-5734, GX-19, HA330, Heberon Alfa R , Heparin, Hesperidin, hydrocortisone, Hyperbaric Oxygen, Ibrutinib, Ibudilast, Ibuprofen, Icatibant, Icosapent ethyl, IFX-1, Iloprost , ILT101, Imatinib, IMM-101, IMU-838, Indomethacin, Infliximab, INM005, INO-4800, Interferon Alfa, interferon beta, Isoflurane, Isoprinosine, Isotretinoin , itolizumab, ITRACONAZOLE, Ivermectin, Ixekizumab , Jakotinib hydrochloride, JS016, KB109 , KBP-201 , Ketamine, Khorasan asafoetida, kolimycin, Lactoferrin, lanadelumab, Lariam, L-ascorbic acid, LAU-7b, LB1148, L-cysteine, Ledipasvir, Leflunomide, Lenalidomide, Lenzilumab, Leronlimab, Levamisole, Levilimab, Lianhua Qingwen , Linagliptin, Lipoic acid, Losartan , Losmapimod , Lucinactant, LY3127804, LY3819253, M5049, Maraviroc, MAS825, Masitinib mesilate, mavrilimumab, MEDI3506, MEFLOQUINE, Melatonin, Melphalan, Meplazumab , Merimepodib, metenkefalin, Metformin, Methotrexate, methylprednisolone , metoprolol tartrate, metronidazole, midazolam, minocycline, MK-5475, Moxibustion , mRNA-1273, MRx-4DP0004, Mucodentol, MultiStem, MVC-COV1901, Mycobacterium w, N acetylcysteine, N-803, NA-831, N-Acetyl cysteine, NADROPARIN, Nafamostat Mesylate, Naltrexone, Namilumab, nangibotide, nanocurcumin, Naproxen, NasoVAX, Nebulised heparin, Nelfinavir, Niacin-Tannin, Niclosamide, Nifedipine, Nintedanib , Nitazoxanide , Nivolumab , Noscapine, Novaferon, NP-120 , NT-I7, OctaplasLG, olchicine/Statins, Olokizumab, Omegaven, Omeprazole, OP-101, Opaganib, Oseltamivir, Otilimab, Ozanimod, Pamrevlumab, PB1046, Pegylated interferon lambda, Pembrolizumab, Pentaglobin, Pentoxifylline, Pertuzumab, PH94B, PHR160, Piclidenoson, Pioglitazone, Pirfenidone, Plitidepsin, PLX-PAD, Povidone-iodine, Prasugrel Hydrochloride, Prazosin, Prednisolone, Previfenon, Probiorinse, Progesterone, Prolongin, Propranolol Hydrochloride, Proxalutamide, PSC-04, PTC299, PUL-042, Pulmozyme, Pyramax, Pyridostigmine, qingfei detoxification, raltagravir, Ramelteon, Ramipril, Rapamycin, Ravulizumab, Razuprotafib, RBT-9, rednisolone, Reginmune , REGN10933, REGN10987, Remdesivir, Remestemcel-L, RESP301, resveratrol, Ribavirin, RITONAVIR, Ritonavir , Rivaroxaban, RPH-104, RTB101, Ruxolitinib, SAB-185, SAR443122, SARILUMAB, SBI-101, SCB-2019, SCTA01, Secukinumab, Secuquinumab, selenium, Selinexor, Septimeb, Sevoflurane, Shenfu, Sildenafil, Silibinin, Siltuximab, Silymarin, simvastatin, Sirolimus, Sirukumab, Sitagliptin, SivoMixx , Sofosbuvir, Spironolactone, STI-1499, sulfamethoxazole, sulfate, Sulodexide, TAK-671, Tamiflu, Tamoxifen, Tanacetum parthenium, Tannin, Tanreqing, TD-0903, TD139, Teicoplanin IV, Telmisartan, Tenecteplase, Tenofovir, Teprenone, Tetrandrine, thalidomide, Thymalfasin, Thymoquinone, Thymosin Alpha 1 , Tinzaparin , Tirofiban, TJ003234, TL-895, TMV-083, Tociliuzumab, Tradipitant, Tramadol, Tranexamic acid, Tranilast, Trastuzumab, Triazavirin, Tricholoma, tridecactide, Trifluoperazine, TRV027, TXA127, TY027, Ulinastatin, Umnifenovir, V591, vadadustat, VAFIDEMSTAT, Valsartan (Diovan), Vancomycin, Vazegepant , Velpatasvir, Veru-111, Videsil, Vidofludimus calcium, Virazole, VPM1002, XAV-19, XC221, Xinguan-1 , Xinguan-2 , Xiyanping , XPro1595, Xuebijing , yohimbine, Zanubrutinib, Zilucoplan, ZingiVir H, ?-Globulin
1 COVID-19 PIPELINE ANALYSIS
1.1 Pipeline Snapshot- September 2020
1.2 Drug and Vaccine Pipeline Candidates by Phase
1.3 Drug and Vaccine Pipeline Candidates by New Molecular Entity (NME)
1.4 Drug and Vaccine Pipeline Candidates by Mechanism of Action
2 COVID-19 CLINICAL TRIALS ANALYSIS
2.1 COVID-19 Clinical Trials Overview, 2020
2.2 Premium Insights into Clinical Trials
2.2.1 United States is the largest country in COVID-19 Clinical Trials
2.2.2 COVID-19 Clinical Trials by Region
2.2.3 One-Fifth of trials are directly sponsored by Companies
2.2.4 Companies participating in Trials
2.2.5 Major Drugs under Development in COVID-19 Clinical Trials
2.2.6 Trials in Emerging and Developing Economies
3 REGION-WISE COVID-19 CLINICAL TRIALS
3.1 North America COVID-19 Clinical Trials by Country
3.2 Europe COVID-19 Clinical Trials by Country
3.3 Eastern Mediterranean COVID-19 Clinical Trials by Country
3.4 Africa COVID-19 Clinical Trials by Country
3.5 South and Central America COVID-19 Clinical Trials by Country
3.6 South East Asia COVID-19 Clinical Trials by Country
3.7 Western Pacific COVID-19 Clinical Trials by Country
4 CLINICAL TRIALS TRENDS TO 2025
4.1 Phase wise COVID-19 Clinical Trials
4.2 COVID-19 Trials by Recruitment Status
4.3 Trial Type wise COVID-19 Clinical Trials
5 COVID-19 AVERAGE ENROLLMENT TRENDS
5.1 Enrollment in COVID-19 Trials by Region
5.2 Enrollment in Top 10 Countries- COVID-19 Trials
5.3 Enrollment in COVID-19 Trials by Phase
5.4 Enrollment in COVID-19 Trials by Status
5.5 Enrollment in COVID-19 Trials by Type of Trial
6 COMPANY LEVEL ANALYSIS
6.1 COVID-19 Trials by Sponsor Type
6.2 COVID-19 Average Enrollment by Sponsor Type
6.2.1 Subjects Recruited by Leading Sponsors
6.2.2 Leading Institutes participating in Clinical Trials
7 RECENT CLINICAL TRIALS- SNAPSHOTS
7.1 Phase 0 Trials
7.2 Phase 1 Trials
7.3 Phase 2 Trials
7.4 Phase 3 Trials
7.5 Phase 4 Trials
8 COVID-19 COMPANIES AND DRUG CANDIDATES IN PHASE
8.1 AbCellera Biologics Inc
8.2 Ansun Biopharma Inc
8.3 AryoGen
8.4 AstraZeneca Plc
8.5 Bellerophon Therapeutics
8.6 Biocad
8.7 CytoDyn Inc
8.8 Eli Lilly and Company
8.9 FUJIFILM Toyama Chemical Co Ltd
8.10 Fulcrum Therapeutics
8.11 Gilead Sciences Inc
8.12 Insmed Inc
8.13 International Biotech Center Generium
8.14 Kowsar Biotechnology
8.15 Moderna Therapeutics Inc
8.16 Octapharma
8.17 OncoImmune Inc
8.18 Regeneron Pharmaceuticals Inc
8.19 Romark Laboratories LC
8.20 Serum Institute of India Ltd
8.21 Sinovac Biotech Ltd
8.22 Swedish Orphan Biovitrum AB
8.23 Vanda Pharmaceuticals Inc
8.24 Wuhan Institute of Biological Products Co Ltd
8.25 Abivax SA
8.26 Beijing Defengrei Biotechnology
8.27 Biohaven Pharmaceuticals Inc
8.28 BioNTech SE
8.29 Biophytis SA
8.30 Evelo Biosciences
8.31 FibroGen Inc
8.32 Immunic Inc
8.33 Inmunova SA
8.34 NeuroActiva Inc
8.35 Ono Pharmaceutical Co Ltd
8.36 PTC Therapeutics Inc
8.37 RedHill Biopharma Ltd
8.38 Swedish Orphan Biovitrum AB
8.39 Thirty respiratory Ltd
9 COVID-19 COMPANIES AND DRUG CANDIDATES IN PHASE
9.1 4D Pharma PLC
9.2 4D Pharma PLC
9.3 AB Science
9.4 Acerta Pharma B.V.
9.5 AI Therapeutics
9.6 Aldeyra Therapeutics Inc
9.7 Altum Pharmaceuticals Inc
9.8 Amarin Corp
9.9 Anhui Zhifei Longcom Biopharmaceutical
9.10 Apeiron Biologics GMBH
9.11 Applied Therapeutics Inc
9.12 Ascletis Pharma Inc
9.13 AstraZeneca Plc
9.14 Atea Pharmaceuticals Inc
9.15 aTyr Pharma Inc
9.16 Beech Tree Labs
9.17 BeiGene
9.18 BerGenBio SA
9.19 Blade Therapeutics Inc
9.20 Boehringer Ingelheim
9.21 Bristol-Myers Squibb Co
9.22 Bukwang Pharm Co Ltd
9.23 CalciMedica Inc
9.24 Can-Fite BioPharma Ltd
9.25 CinnaGen Co
9.26 Confluence Life Sciences Inc
9.27 Constant Therapeutics LLC
9.28 Eiger BioPharmaceuticals Inc
9.29 Eli Lilly and Company
9.30 Galecto Biotech
9.31 Genentech
9.32 GeneOne Life Science Inc
9.33 Globavir Biosciences Inc
9.34 Grifols SA
9.35 Heber Biotech SA
9.36 Heron Therapeutics Inc
9.37 Hope Biosciences LLC
9.38 Immune Therapeutics Inc
9.39 Inotrem SAA
9.40 Janssen Pharmaceuticals
9.41 Kancera AB
9.42 Karyopharm Therapeutics Inc
9.43 Kinevant Sciences Ltd
9.44 Laurent Pharmaceuticals Inc
9.45 Merck & Co
9.46 NeuroClear Technologies Inc
9.47 Novartis
9.48 Novartis AG
9.49 Novavax Inc
9.50 Pfizer Inc
9.51 PharmaMar SA
9.52 Pharming Group NV
9.53 PhaseBio Pharmaceuticals Inc
9.54 Pulmotect Inc
9.55 Reata Pharmaceuticals Inc
9.56 Relief Therapeutics Holdings AG
9.57 Renibus Therapeutics Inc
9.58 resTORbio Inc
9.59 Ridgeback Biotherapeutics LP
9.60 Roche AG
9.61 Rovi Corp
9.62 sanofi aventis
9.63 Sanotize Research and Development Corp
9.64 Synairgen Plc
9.65 Tianjin CanSino Biotechnology Inc
9.66 Tobira Therapeutics Inc
9.67 UCB Pharma
9.68 Vicore Pharma Holding AB
9.69 Viriom Inc
9.70 Vitaeris Inc
9.71 Xenothera
9.72 Zydus Cadila
9.73 Akari Therapeutics Plc
9.74 Arcturus Therapeutics Holdings Inc
9.75 Bharat Biotech International Ltd
9.76 Celularity Inc
9.77 Genexine Inc
9.78 I-MAB Biopharma Co Ltd
9.79 Immunitor Inc
9.80 Inovio Pharmaceuticals Inc
9.81 Janssen Pharmaceuticals
9.82 Janssen Vaccines and Prevention B.V
9.83 Kamada Ltd
9.84 Pacific Meinuoke Bio Pharmaceutical
9.85 Takara Bio Inc
9.86 Telios Pharmaceuticals Inc
10 COVID-19 COMPANIES AND DRUG CANDIDATES IN PHASE
10.1 Ampio Pharmaceuticals Inc
10.2 Ampio Pharmaceuticals Inc
10.3 argenx SE
10.4 AstraZeneca Plc
10.5 Atossa Therapeutics Inc
10.6 BioCryst Pharmaceuticals Inc
10.7 Brii Biosciences Ltd
10.8 Celltrion Inc
10.9 Clear Creek Bio
10.10 Clover Biopharmaceuticals Inc
10.11 Corvus Pharmaceuticals Inc
10.12 CureVac AG
10.13 Denali Therapeutics Inc
10.14 Dynavax Technologies Corp
10.15 Enlivex Therapeutics Ltd
10.16 ExeGi Pharma LLc
10.17 Fate Therapeutics Inc
10.18 Genexine Inc
10.19 Helperby Therapeutics Group Ltd
10.20 ImmuneMed Inc
10.21 Izana Bioscience
10.22 Medicago Inc
10.23 Palatin Technologies Inc
10.24 Pluristem Therapeutics Inc
10.25 ReiThera Srl
10.26 SAB Biotherapeutics Inc
10.27 Shanghai Junshi Bioscience Co Ltd
10.28 Sinocelltech Ltd
10.29 Themis Bioscience GmBH
10.30 Vaxine Pty Ltd
10.31 ychan Pte. Ltd.
11 COVID-19 COMPANIES AND DRUG CANDIDATES IN IND/CTA FILED PHASE
11.1 Agenus Inc
11.2 Algernon Pharmaceuticals Inc
11.3 Altimmune Inc
11.4 Better Life Pharmaceuticals Inc
11.5 Capricor Therapeutics
11.6 CytoAgents
11.7 Daewoong Pharmaceutical Co Ltd
11.8 Diffusion Pharmaceuticals Inc
11.9 Ensysce Biosciences Inc
11.10 GLW Pharma
11.11 ImmunityBio Inc
11.12 Kazia Therapeutics Ltd
11.13 Komipharm International Co Ltd
11.14 NovaLead Pharma Pvt Ltd
11.15 Novoteris LLC
11.16 Oncology Venture US
11.17 Organicell Regenerative Medicine Inc
11.18 Personalized Stem Cells Inc
11.19 Sun Pharmaceutical Industries Ltd
11.20 TC BioPharm Ltd
11.21 Union Therapeutics AS
11.22 VSY Biotechnology BV
11.23 Walvax Biotechnology Co Ltd
12 COVID-19 COMPANIES AND DRUG CANDIDATES IN PRECLINICAL PHASE
12.1 60 Degrees Pharmaceuticals
12.2- 7 Hills Pharma LLC
12.3 AbbVie Inc
12.4 Abnova Corporation
12.5 Abound Bio
12.6 Acer Therapeutics Inc
12.7 Adagio Therapeutics
12.8 Adaptive Phage Therapeutics
12.9 AdaptVac
12.10 AIM ImmunoTech Inc
12.11 Akers Biosciences Inc
12.12 Aldeyra Therapeutics Inc
12.13 Anivive Lifesciences
12.14 Aptorum Group Limited
12.15 AriBio Co Ltd
12.16 Aridis Pharmaceuticals Inc
12.17 ARMS Pharmaceutical LLC
12.18 Array BioPharma Inc
12.19 AstraZeneca Plc
12.20 Atossa Therapeutics Inc
12.21 Berlin Cures Holding AG
12.22 Beyond Air Inc
12.23 BeyondSpring Inc
12.24 BioNet- Asia Co Ltd
12.25 BioNtech SE
12.26 Bio-Thera Solutions
12.27 BlueSky Immunotherapies
12.28 Bolder BioTechnology
12.29 Capricor Therapeutics Inc
12.30 CEL-SCI Corporation
12.31 Centivax
12.32 Chimeron Bio
12.33 ChromaDex
12.34 Cidara Therapeutics Inc
12.35 Cocrystal Pharma Inc
12.36 Codagenix Inc
12.37 COVAXX
12.38 COVID-19 Vaccine Corporation
12.39 Daiichi Sankyo Co Ltd
12.40 Delta
12.41 Dilafor AB
12.42 Dong Wha Pharmaceutical
12.43 Eagle Pharmaceuticals Inc
12.44 Elixirgen Therapeutics Inc
12.45 Emergent BioSolutions Inc
12.46 ENDECE LLC
12.47 Ennaid Therapeutics LLC
12.48 Entos Pharmaceuticals Inc
12.49 EpicentRx Inc
12.50 Epitopoietic Research Corporation
12.51 EpiVax Inc
12.52 eTheRNA Immunotherapies NV
12.53 EUCYT Laboratories LLC
12.54 Excision BioTherapeutics
12.55 ExeVir Bio
12.56 FibroGenesis LLC
12.57 FirstWave Bio
12.58 Flow Pharma Inc
12.59 GeneOne Life Science
12.60 GeoVax Labs
12.61 GigaGen Inc
12.62 Ginkgo Bioworks
12.63 Glycovax Pharma
12.64 GRDG Sciences
12.65 Grifols SA
12.66 HaloVax LLC
12.67 Heat Biologics Inc
12.68 HiFiBiO
12.69 Hoth Therapeutics
12.70 iBio Inc
12.71 IDBiologics Inc
12.72 IGY Life Sciences
12.73 Immodulon Therapeutics
12.74 IMV Inc
12.75 Inimmune
12.76 Innovation Pharmaceuticals Inc
12.77 INTELLiSTEM Technologies Inc
12.78 Isotechnika
12.79 Joseah Biopharma
12.80 Lineage Cell Therapeutics
12.81 LineaRx Inc
12.82 MedinCell S.A.
12.83 Meissa Vaccines Inc
12.84 Memgen Corp
12.85 Merck & Co
12.86 Molecular Partners AG
12.87 Moleculin Biotech inc
12.88 Ology Bioservices Inc
12.89 Oncogenuity Inc
12.90 Oncology Venture
12.91 Oncolys BioPharma
12.92 Onconova Therapeutics
12.93 Oragenics Inc
12.94 OSE Immunotherapeutics
12.95 OyaGen Inc
12.96 PDS Biotechnology Corporation
12.97 PepTC Vaccines Limited
12.98 Precision NanoSystems Inc
12.99 Primmune Therapeutics Inc
12.100 Proteostasis Therapeutics Inc
12.101 Providence Therapeutics
12.102 Q BioMed Inc
12.103 Qualigen Therapeutics Inc
12.104 Radikal Therapeutics Inc
12.105 Rapa Therapeutics
12.106 Regeneron Pharmaceuticals Inc
12.107 Repurpose AI
12.108 Resverlogix Corp
12.109 RNAimmune Inc
12.110 Saiba AG
12.111 Sanofi pasteur
12.112 Sanofi SA
12.113 Secarna Pharmaceuticals GmbH&Co.KG
12.114 Selva Therapeutics
12.115 Senhwa Biosciences
12.116 Senzer Pharmaceuticals
12.117 Shanghai Junshi Biosciences Co Ltd
12.118 SK bioscience
12.119 Sorrento Therapeutics Inc
12.120 Spring Bank Pharmaceuticals Inc
12.121 Stabilitech Biopharma Ltd
12.122 Starpharma Holdings Ltd
12.123 Stemirna Therapeutics Co Ltd
12.124 Tonix Pharmaceuticals Holding Corp
12.125 UbiVac LLC
12.126 Vaxart Inc
12.127 Vaxil Bio Ltd
12.128 VBI Vaccines Inc
12.129 Verndari Inc
12.130 Vir Biotechnology Inc
12.131 Vivtex Corporation
12.132 Xiamen Innovax Biotech
12.133 YUMAB Gmbh
12.134 Zhittya Genesis Medicine
12.135 Zydus Cadila
13 COVID-19 COMPANIES AND DRUG CANDIDATES IN RESEARCH PHASE
13.1 48Hour Discovery Inc Research Phase Pipeline Analysis
13.1.1 Current Status of the Pipeline Candidate
13.1.2 Drug Overview
13.1.3 Drug Mechanism of Action
13.1.4 Route of Administration
13.1.5 Companies involved in pipeline development
13.2 13.2 48Hour Discovery Inc
13.3 A2A Pharmaceuticals Inc
13.4 Active Motif Inc
13.5 Adaptive Biotechnologies Inc
13.6 AdaptVac
13.7 Affinity Biosciences
13.8 AffyXell Therapeutics
13.9 AIkido Pharma Inc
13.10 Airway Therapeutics Inc
13.11 AJ Vaccines A/S
13.12 Akshaya Bio Inc
13.13 Aldevron
13.14 Aligos Therapeutics Inc
13.15 Alkido Pharma Inc
13.16 Amarillo Biosciences Inc
13.17 ANA Therapeutics
13.18 Anixa Biosciences Inc
13.19 Applied Biology Inc
13.20 Arbutus Biopharma Corp
13.21 Arrowhead Pharmaceuticals Inc
13.22 ARTES Biotechnology Gmbh
13.23 AstraZeneca Plc
13.24 Atreca Inc
13.25 AUM LifeTech Inc
13.26 Avacta Life Sciences Limited
13.27 Avalon GloboCare Corp
13.28 AvantGen Inc
13.29 Axon Neuroscience SE
13.30 Biocad
13.31 Biological E. Limited
13.32 Bioxytran Inc
13.33 Bold Therapeutics Inc
13.34 BriaCell Therapeutics Corp
13.35 CellPoint LLC
13.36 Chugai Pharmabody Research
13.37 Cobra Biologics Ltd
13.38 Codagenix Inc
13.39 Codiak BioSciences Inc
13.40 Cytovia Therapeutics Inc
13.41 Cyxone AB
13.42 Dyadic International Inc
13.43 Emergent BioSolutions Inc
13.44 Emergex vaccines Ltd
13.45 EpiVax Inc
13.46 Evotec Biologics
13.47 Exscientia Ltd
13.48 Generex Biotechnology Corp
13.49 Glycovax Pharma Inc
13.50 GT Biopharma
13.51 Hemogenyx Pharmaceuticals Plc
13.52 Hetero Labs Ltd
13.53 HiFiBiO Therapeutics
13.54 Hoth Therapeutics Inc
13.55 ImmuneCyte Inc
13.56 Immunomic Therapeutics Inc
13.57 ImmunoPrecise Antibodies Ltd
13.58 Imophoron Ltd
13.59 ImStem Biotechnology
13.60 Intravacc
13.61 Iontas Ltd
13.62 IVIEW Therapeutics Inc
13.63 Jiangsu Alphamab Biopharmaceuticals
13.64 kali-extracts Inc
13.65 Kleo Pharmaceuticals Inc
13.66 Ligandal Inc
13.67 Mabpharm Ltd
13.68 Manhattan BioSolutions LLC
13.69 Mateon Therapeutics Inc
13.70 Medivir AB
13.71 Memo Therapeutics AG
13.72 MigVax Ltd
13.73 Mymetics Corporation
13.74 NanoViricides Inc
13.75 Nascent Biotech Inc
13.76 Neovii Biotech
13.77 Neurimmune AG
13.78 Neutrolis Therapeutics
13.79 NuGenerex Immuno-Oncology Inc
13.80 OliX Pharmaceuticals Inc
13.81 OncoSec Medical Inc
13.82 Orgenesis Inc
13.83 OSIVAX
13.84 Panacea Biotec Ltd
13.85 PeptiDream Inc
13.86 Pfizer Inc
13.87 Phylex BioSciences Inc
13.88 Phytoption LLC
13.89 Pneumagen Ltd
13.90 Predictive Oncology
13.91 Prellis Biologics Inc
13.92 Prismic Pharmaceuticals
13.93 Qurient Co Ltd
13.94 Recce Pharmaceuticals
13.95 Regeneron Pharmaceuticals Inc
13.96 Replicate Bioscience
13.97 Sanofi Pasteur
13.98 Sarepta Therapeutics Inc
13.99 Scancell Holdings plc
13.100 Sirnaomics Inc
13.101 Sirona Biochem Corp
13.102 SmartPharm Therapeutics Inc
13.103 Soligenix Inc
13.104 SOM Biotech
13.105 Sosei Heptares
13.106 Sunshine Biopharma Inc
13.107 Synlogic Inc
13.108 Takeda
13.109 Takeda Pharmaceutical Company Ltd
13.110 Takis Biotech
13.111 Tetra Bio Pharma
13.112 Tevogen Bio
13.113 TFF pharmaceuticals Inc
13.114 Twist Bioscience Corp
13.115 Ufovax Inc
13.116 UMN Pharma Inc
13.117 United Biomedical Inc
13.118 Valneva SE
13.119 Valo Therapeutics Ltd
13.120 Vanda Pharmaceuticals Inc
13.121 Vaxil BioTherapeutics
13.122 Vir Biotechnology Inc
13.123 Viravaxx AG
13.124 Virna therapeutics
13.125 Vyripharm Biopharmaceuticals
13.126 WuXi Biologics Inc
13.127 Xbiotech
13.128 XORTX Therapeutics Inc
14 LATEST COVID-19 MARKET DEVELOPMENTS
15. APPENDIX
15.1 Sources and Methodology
15.2 About the Publisher
1.1 Pipeline Snapshot- September 2020
1.2 Drug and Vaccine Pipeline Candidates by Phase
1.3 Drug and Vaccine Pipeline Candidates by New Molecular Entity (NME)
1.4 Drug and Vaccine Pipeline Candidates by Mechanism of Action
2 COVID-19 CLINICAL TRIALS ANALYSIS
2.1 COVID-19 Clinical Trials Overview, 2020
2.2 Premium Insights into Clinical Trials
2.2.1 United States is the largest country in COVID-19 Clinical Trials
2.2.2 COVID-19 Clinical Trials by Region
2.2.3 One-Fifth of trials are directly sponsored by Companies
2.2.4 Companies participating in Trials
2.2.5 Major Drugs under Development in COVID-19 Clinical Trials
2.2.6 Trials in Emerging and Developing Economies
3 REGION-WISE COVID-19 CLINICAL TRIALS
3.1 North America COVID-19 Clinical Trials by Country
3.2 Europe COVID-19 Clinical Trials by Country
3.3 Eastern Mediterranean COVID-19 Clinical Trials by Country
3.4 Africa COVID-19 Clinical Trials by Country
3.5 South and Central America COVID-19 Clinical Trials by Country
3.6 South East Asia COVID-19 Clinical Trials by Country
3.7 Western Pacific COVID-19 Clinical Trials by Country
4 CLINICAL TRIALS TRENDS TO 2025
4.1 Phase wise COVID-19 Clinical Trials
4.2 COVID-19 Trials by Recruitment Status
4.3 Trial Type wise COVID-19 Clinical Trials
5 COVID-19 AVERAGE ENROLLMENT TRENDS
5.1 Enrollment in COVID-19 Trials by Region
5.2 Enrollment in Top 10 Countries- COVID-19 Trials
5.3 Enrollment in COVID-19 Trials by Phase
5.4 Enrollment in COVID-19 Trials by Status
5.5 Enrollment in COVID-19 Trials by Type of Trial
6 COMPANY LEVEL ANALYSIS
6.1 COVID-19 Trials by Sponsor Type
6.2 COVID-19 Average Enrollment by Sponsor Type
6.2.1 Subjects Recruited by Leading Sponsors
6.2.2 Leading Institutes participating in Clinical Trials
7 RECENT CLINICAL TRIALS- SNAPSHOTS
7.1 Phase 0 Trials
7.2 Phase 1 Trials
7.3 Phase 2 Trials
7.4 Phase 3 Trials
7.5 Phase 4 Trials
8 COVID-19 COMPANIES AND DRUG CANDIDATES IN PHASE
8.1 AbCellera Biologics Inc
8.2 Ansun Biopharma Inc
8.3 AryoGen
8.4 AstraZeneca Plc
8.5 Bellerophon Therapeutics
8.6 Biocad
8.7 CytoDyn Inc
8.8 Eli Lilly and Company
8.9 FUJIFILM Toyama Chemical Co Ltd
8.10 Fulcrum Therapeutics
8.11 Gilead Sciences Inc
8.12 Insmed Inc
8.13 International Biotech Center Generium
8.14 Kowsar Biotechnology
8.15 Moderna Therapeutics Inc
8.16 Octapharma
8.17 OncoImmune Inc
8.18 Regeneron Pharmaceuticals Inc
8.19 Romark Laboratories LC
8.20 Serum Institute of India Ltd
8.21 Sinovac Biotech Ltd
8.22 Swedish Orphan Biovitrum AB
8.23 Vanda Pharmaceuticals Inc
8.24 Wuhan Institute of Biological Products Co Ltd
8.25 Abivax SA
8.26 Beijing Defengrei Biotechnology
8.27 Biohaven Pharmaceuticals Inc
8.28 BioNTech SE
8.29 Biophytis SA
8.30 Evelo Biosciences
8.31 FibroGen Inc
8.32 Immunic Inc
8.33 Inmunova SA
8.34 NeuroActiva Inc
8.35 Ono Pharmaceutical Co Ltd
8.36 PTC Therapeutics Inc
8.37 RedHill Biopharma Ltd
8.38 Swedish Orphan Biovitrum AB
8.39 Thirty respiratory Ltd
9 COVID-19 COMPANIES AND DRUG CANDIDATES IN PHASE
9.1 4D Pharma PLC
9.2 4D Pharma PLC
9.3 AB Science
9.4 Acerta Pharma B.V.
9.5 AI Therapeutics
9.6 Aldeyra Therapeutics Inc
9.7 Altum Pharmaceuticals Inc
9.8 Amarin Corp
9.9 Anhui Zhifei Longcom Biopharmaceutical
9.10 Apeiron Biologics GMBH
9.11 Applied Therapeutics Inc
9.12 Ascletis Pharma Inc
9.13 AstraZeneca Plc
9.14 Atea Pharmaceuticals Inc
9.15 aTyr Pharma Inc
9.16 Beech Tree Labs
9.17 BeiGene
9.18 BerGenBio SA
9.19 Blade Therapeutics Inc
9.20 Boehringer Ingelheim
9.21 Bristol-Myers Squibb Co
9.22 Bukwang Pharm Co Ltd
9.23 CalciMedica Inc
9.24 Can-Fite BioPharma Ltd
9.25 CinnaGen Co
9.26 Confluence Life Sciences Inc
9.27 Constant Therapeutics LLC
9.28 Eiger BioPharmaceuticals Inc
9.29 Eli Lilly and Company
9.30 Galecto Biotech
9.31 Genentech
9.32 GeneOne Life Science Inc
9.33 Globavir Biosciences Inc
9.34 Grifols SA
9.35 Heber Biotech SA
9.36 Heron Therapeutics Inc
9.37 Hope Biosciences LLC
9.38 Immune Therapeutics Inc
9.39 Inotrem SAA
9.40 Janssen Pharmaceuticals
9.41 Kancera AB
9.42 Karyopharm Therapeutics Inc
9.43 Kinevant Sciences Ltd
9.44 Laurent Pharmaceuticals Inc
9.45 Merck & Co
9.46 NeuroClear Technologies Inc
9.47 Novartis
9.48 Novartis AG
9.49 Novavax Inc
9.50 Pfizer Inc
9.51 PharmaMar SA
9.52 Pharming Group NV
9.53 PhaseBio Pharmaceuticals Inc
9.54 Pulmotect Inc
9.55 Reata Pharmaceuticals Inc
9.56 Relief Therapeutics Holdings AG
9.57 Renibus Therapeutics Inc
9.58 resTORbio Inc
9.59 Ridgeback Biotherapeutics LP
9.60 Roche AG
9.61 Rovi Corp
9.62 sanofi aventis
9.63 Sanotize Research and Development Corp
9.64 Synairgen Plc
9.65 Tianjin CanSino Biotechnology Inc
9.66 Tobira Therapeutics Inc
9.67 UCB Pharma
9.68 Vicore Pharma Holding AB
9.69 Viriom Inc
9.70 Vitaeris Inc
9.71 Xenothera
9.72 Zydus Cadila
9.73 Akari Therapeutics Plc
9.74 Arcturus Therapeutics Holdings Inc
9.75 Bharat Biotech International Ltd
9.76 Celularity Inc
9.77 Genexine Inc
9.78 I-MAB Biopharma Co Ltd
9.79 Immunitor Inc
9.80 Inovio Pharmaceuticals Inc
9.81 Janssen Pharmaceuticals
9.82 Janssen Vaccines and Prevention B.V
9.83 Kamada Ltd
9.84 Pacific Meinuoke Bio Pharmaceutical
9.85 Takara Bio Inc
9.86 Telios Pharmaceuticals Inc
10 COVID-19 COMPANIES AND DRUG CANDIDATES IN PHASE
10.1 Ampio Pharmaceuticals Inc
10.2 Ampio Pharmaceuticals Inc
10.3 argenx SE
10.4 AstraZeneca Plc
10.5 Atossa Therapeutics Inc
10.6 BioCryst Pharmaceuticals Inc
10.7 Brii Biosciences Ltd
10.8 Celltrion Inc
10.9 Clear Creek Bio
10.10 Clover Biopharmaceuticals Inc
10.11 Corvus Pharmaceuticals Inc
10.12 CureVac AG
10.13 Denali Therapeutics Inc
10.14 Dynavax Technologies Corp
10.15 Enlivex Therapeutics Ltd
10.16 ExeGi Pharma LLc
10.17 Fate Therapeutics Inc
10.18 Genexine Inc
10.19 Helperby Therapeutics Group Ltd
10.20 ImmuneMed Inc
10.21 Izana Bioscience
10.22 Medicago Inc
10.23 Palatin Technologies Inc
10.24 Pluristem Therapeutics Inc
10.25 ReiThera Srl
10.26 SAB Biotherapeutics Inc
10.27 Shanghai Junshi Bioscience Co Ltd
10.28 Sinocelltech Ltd
10.29 Themis Bioscience GmBH
10.30 Vaxine Pty Ltd
10.31 ychan Pte. Ltd.
11 COVID-19 COMPANIES AND DRUG CANDIDATES IN IND/CTA FILED PHASE
11.1 Agenus Inc
11.2 Algernon Pharmaceuticals Inc
11.3 Altimmune Inc
11.4 Better Life Pharmaceuticals Inc
11.5 Capricor Therapeutics
11.6 CytoAgents
11.7 Daewoong Pharmaceutical Co Ltd
11.8 Diffusion Pharmaceuticals Inc
11.9 Ensysce Biosciences Inc
11.10 GLW Pharma
11.11 ImmunityBio Inc
11.12 Kazia Therapeutics Ltd
11.13 Komipharm International Co Ltd
11.14 NovaLead Pharma Pvt Ltd
11.15 Novoteris LLC
11.16 Oncology Venture US
11.17 Organicell Regenerative Medicine Inc
11.18 Personalized Stem Cells Inc
11.19 Sun Pharmaceutical Industries Ltd
11.20 TC BioPharm Ltd
11.21 Union Therapeutics AS
11.22 VSY Biotechnology BV
11.23 Walvax Biotechnology Co Ltd
12 COVID-19 COMPANIES AND DRUG CANDIDATES IN PRECLINICAL PHASE
12.1 60 Degrees Pharmaceuticals
12.2- 7 Hills Pharma LLC
12.3 AbbVie Inc
12.4 Abnova Corporation
12.5 Abound Bio
12.6 Acer Therapeutics Inc
12.7 Adagio Therapeutics
12.8 Adaptive Phage Therapeutics
12.9 AdaptVac
12.10 AIM ImmunoTech Inc
12.11 Akers Biosciences Inc
12.12 Aldeyra Therapeutics Inc
12.13 Anivive Lifesciences
12.14 Aptorum Group Limited
12.15 AriBio Co Ltd
12.16 Aridis Pharmaceuticals Inc
12.17 ARMS Pharmaceutical LLC
12.18 Array BioPharma Inc
12.19 AstraZeneca Plc
12.20 Atossa Therapeutics Inc
12.21 Berlin Cures Holding AG
12.22 Beyond Air Inc
12.23 BeyondSpring Inc
12.24 BioNet- Asia Co Ltd
12.25 BioNtech SE
12.26 Bio-Thera Solutions
12.27 BlueSky Immunotherapies
12.28 Bolder BioTechnology
12.29 Capricor Therapeutics Inc
12.30 CEL-SCI Corporation
12.31 Centivax
12.32 Chimeron Bio
12.33 ChromaDex
12.34 Cidara Therapeutics Inc
12.35 Cocrystal Pharma Inc
12.36 Codagenix Inc
12.37 COVAXX
12.38 COVID-19 Vaccine Corporation
12.39 Daiichi Sankyo Co Ltd
12.40 Delta
12.41 Dilafor AB
12.42 Dong Wha Pharmaceutical
12.43 Eagle Pharmaceuticals Inc
12.44 Elixirgen Therapeutics Inc
12.45 Emergent BioSolutions Inc
12.46 ENDECE LLC
12.47 Ennaid Therapeutics LLC
12.48 Entos Pharmaceuticals Inc
12.49 EpicentRx Inc
12.50 Epitopoietic Research Corporation
12.51 EpiVax Inc
12.52 eTheRNA Immunotherapies NV
12.53 EUCYT Laboratories LLC
12.54 Excision BioTherapeutics
12.55 ExeVir Bio
12.56 FibroGenesis LLC
12.57 FirstWave Bio
12.58 Flow Pharma Inc
12.59 GeneOne Life Science
12.60 GeoVax Labs
12.61 GigaGen Inc
12.62 Ginkgo Bioworks
12.63 Glycovax Pharma
12.64 GRDG Sciences
12.65 Grifols SA
12.66 HaloVax LLC
12.67 Heat Biologics Inc
12.68 HiFiBiO
12.69 Hoth Therapeutics
12.70 iBio Inc
12.71 IDBiologics Inc
12.72 IGY Life Sciences
12.73 Immodulon Therapeutics
12.74 IMV Inc
12.75 Inimmune
12.76 Innovation Pharmaceuticals Inc
12.77 INTELLiSTEM Technologies Inc
12.78 Isotechnika
12.79 Joseah Biopharma
12.80 Lineage Cell Therapeutics
12.81 LineaRx Inc
12.82 MedinCell S.A.
12.83 Meissa Vaccines Inc
12.84 Memgen Corp
12.85 Merck & Co
12.86 Molecular Partners AG
12.87 Moleculin Biotech inc
12.88 Ology Bioservices Inc
12.89 Oncogenuity Inc
12.90 Oncology Venture
12.91 Oncolys BioPharma
12.92 Onconova Therapeutics
12.93 Oragenics Inc
12.94 OSE Immunotherapeutics
12.95 OyaGen Inc
12.96 PDS Biotechnology Corporation
12.97 PepTC Vaccines Limited
12.98 Precision NanoSystems Inc
12.99 Primmune Therapeutics Inc
12.100 Proteostasis Therapeutics Inc
12.101 Providence Therapeutics
12.102 Q BioMed Inc
12.103 Qualigen Therapeutics Inc
12.104 Radikal Therapeutics Inc
12.105 Rapa Therapeutics
12.106 Regeneron Pharmaceuticals Inc
12.107 Repurpose AI
12.108 Resverlogix Corp
12.109 RNAimmune Inc
12.110 Saiba AG
12.111 Sanofi pasteur
12.112 Sanofi SA
12.113 Secarna Pharmaceuticals GmbH&Co.KG
12.114 Selva Therapeutics
12.115 Senhwa Biosciences
12.116 Senzer Pharmaceuticals
12.117 Shanghai Junshi Biosciences Co Ltd
12.118 SK bioscience
12.119 Sorrento Therapeutics Inc
12.120 Spring Bank Pharmaceuticals Inc
12.121 Stabilitech Biopharma Ltd
12.122 Starpharma Holdings Ltd
12.123 Stemirna Therapeutics Co Ltd
12.124 Tonix Pharmaceuticals Holding Corp
12.125 UbiVac LLC
12.126 Vaxart Inc
12.127 Vaxil Bio Ltd
12.128 VBI Vaccines Inc
12.129 Verndari Inc
12.130 Vir Biotechnology Inc
12.131 Vivtex Corporation
12.132 Xiamen Innovax Biotech
12.133 YUMAB Gmbh
12.134 Zhittya Genesis Medicine
12.135 Zydus Cadila
13 COVID-19 COMPANIES AND DRUG CANDIDATES IN RESEARCH PHASE
13.1 48Hour Discovery Inc Research Phase Pipeline Analysis
13.1.1 Current Status of the Pipeline Candidate
13.1.2 Drug Overview
13.1.3 Drug Mechanism of Action
13.1.4 Route of Administration
13.1.5 Companies involved in pipeline development
13.2 13.2 48Hour Discovery Inc
13.3 A2A Pharmaceuticals Inc
13.4 Active Motif Inc
13.5 Adaptive Biotechnologies Inc
13.6 AdaptVac
13.7 Affinity Biosciences
13.8 AffyXell Therapeutics
13.9 AIkido Pharma Inc
13.10 Airway Therapeutics Inc
13.11 AJ Vaccines A/S
13.12 Akshaya Bio Inc
13.13 Aldevron
13.14 Aligos Therapeutics Inc
13.15 Alkido Pharma Inc
13.16 Amarillo Biosciences Inc
13.17 ANA Therapeutics
13.18 Anixa Biosciences Inc
13.19 Applied Biology Inc
13.20 Arbutus Biopharma Corp
13.21 Arrowhead Pharmaceuticals Inc
13.22 ARTES Biotechnology Gmbh
13.23 AstraZeneca Plc
13.24 Atreca Inc
13.25 AUM LifeTech Inc
13.26 Avacta Life Sciences Limited
13.27 Avalon GloboCare Corp
13.28 AvantGen Inc
13.29 Axon Neuroscience SE
13.30 Biocad
13.31 Biological E. Limited
13.32 Bioxytran Inc
13.33 Bold Therapeutics Inc
13.34 BriaCell Therapeutics Corp
13.35 CellPoint LLC
13.36 Chugai Pharmabody Research
13.37 Cobra Biologics Ltd
13.38 Codagenix Inc
13.39 Codiak BioSciences Inc
13.40 Cytovia Therapeutics Inc
13.41 Cyxone AB
13.42 Dyadic International Inc
13.43 Emergent BioSolutions Inc
13.44 Emergex vaccines Ltd
13.45 EpiVax Inc
13.46 Evotec Biologics
13.47 Exscientia Ltd
13.48 Generex Biotechnology Corp
13.49 Glycovax Pharma Inc
13.50 GT Biopharma
13.51 Hemogenyx Pharmaceuticals Plc
13.52 Hetero Labs Ltd
13.53 HiFiBiO Therapeutics
13.54 Hoth Therapeutics Inc
13.55 ImmuneCyte Inc
13.56 Immunomic Therapeutics Inc
13.57 ImmunoPrecise Antibodies Ltd
13.58 Imophoron Ltd
13.59 ImStem Biotechnology
13.60 Intravacc
13.61 Iontas Ltd
13.62 IVIEW Therapeutics Inc
13.63 Jiangsu Alphamab Biopharmaceuticals
13.64 kali-extracts Inc
13.65 Kleo Pharmaceuticals Inc
13.66 Ligandal Inc
13.67 Mabpharm Ltd
13.68 Manhattan BioSolutions LLC
13.69 Mateon Therapeutics Inc
13.70 Medivir AB
13.71 Memo Therapeutics AG
13.72 MigVax Ltd
13.73 Mymetics Corporation
13.74 NanoViricides Inc
13.75 Nascent Biotech Inc
13.76 Neovii Biotech
13.77 Neurimmune AG
13.78 Neutrolis Therapeutics
13.79 NuGenerex Immuno-Oncology Inc
13.80 OliX Pharmaceuticals Inc
13.81 OncoSec Medical Inc
13.82 Orgenesis Inc
13.83 OSIVAX
13.84 Panacea Biotec Ltd
13.85 PeptiDream Inc
13.86 Pfizer Inc
13.87 Phylex BioSciences Inc
13.88 Phytoption LLC
13.89 Pneumagen Ltd
13.90 Predictive Oncology
13.91 Prellis Biologics Inc
13.92 Prismic Pharmaceuticals
13.93 Qurient Co Ltd
13.94 Recce Pharmaceuticals
13.95 Regeneron Pharmaceuticals Inc
13.96 Replicate Bioscience
13.97 Sanofi Pasteur
13.98 Sarepta Therapeutics Inc
13.99 Scancell Holdings plc
13.100 Sirnaomics Inc
13.101 Sirona Biochem Corp
13.102 SmartPharm Therapeutics Inc
13.103 Soligenix Inc
13.104 SOM Biotech
13.105 Sosei Heptares
13.106 Sunshine Biopharma Inc
13.107 Synlogic Inc
13.108 Takeda
13.109 Takeda Pharmaceutical Company Ltd
13.110 Takis Biotech
13.111 Tetra Bio Pharma
13.112 Tevogen Bio
13.113 TFF pharmaceuticals Inc
13.114 Twist Bioscience Corp
13.115 Ufovax Inc
13.116 UMN Pharma Inc
13.117 United Biomedical Inc
13.118 Valneva SE
13.119 Valo Therapeutics Ltd
13.120 Vanda Pharmaceuticals Inc
13.121 Vaxil BioTherapeutics
13.122 Vir Biotechnology Inc
13.123 Viravaxx AG
13.124 Virna therapeutics
13.125 Vyripharm Biopharmaceuticals
13.126 WuXi Biologics Inc
13.127 Xbiotech
13.128 XORTX Therapeutics Inc
14 LATEST COVID-19 MARKET DEVELOPMENTS
15. APPENDIX
15.1 Sources and Methodology
15.2 About the Publisher
